BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31790386)

  • 1. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
    Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
    PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting miRNA Targets by Integrating Gene Regulatory Knowledge with Expression Profiles.
    Zhang W; Le TD; Liu L; Zhou ZH; Li J
    PLoS One; 2016; 11(4):e0152860. PubMed ID: 27064982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative network-based approach identifies key genetic elements in breast invasive carcinoma.
    Hamed M; Spaniol C; Zapp A; Helms V
    BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S2. PubMed ID: 26040466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying miRNA-mRNA regulatory relationships in breast cancer with invariant causal prediction.
    Pham VV; Zhang J; Liu L; Truong B; Xu T; Nguyen TT; Li J; Le TD
    BMC Bioinformatics; 2019 Mar; 20(1):143. PubMed ID: 30876399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
    Xu T; Le TD; Liu L; Wang R; Sun B; Li J
    PLoS One; 2016; 11(4):e0152792. PubMed ID: 27035433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network-based method for identifying cancer driver genes based on node control centrality.
    Li F; Li H; Shang J; Liu JX; Dai L; Liu X; Li Y
    Exp Biol Med (Maywood); 2023 Feb; 248(3):232-241. PubMed ID: 36573462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIBNA: a network-based node importance approach for identifying breast cancer drivers.
    Chaudhary MS; Pham VVH; Le TD
    Bioinformatics; 2021 Sep; 37(17):2521-2528. PubMed ID: 33677485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DriverGroup: a novel method for identifying driver gene groups.
    Pham VVH; Liu L; Bracken CP; Goodall GJ; Li J; Le TD
    Bioinformatics; 2020 Dec; 36(Suppl_2):i583-i591. PubMed ID: 33381812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
    Jayavelu ND; Bar N
    BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
    Peng F; Xiong L; Tang H; Peng C; Chen J
    Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs regulate tumor cell plasticity.
    Liu B; Sun L; Song E
    Sci China Life Sci; 2013 Oct; 56(10):886-90. PubMed ID: 24091685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNCDatabase: a database of non-coding cancer drivers.
    Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
    Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.